Barclays’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
Other funds holding INGN
AC
VCM
DCM
Barclays's INGN Position: Q1 2026 in Review
Barclays reduced its Inogen (INGN) stake by 47% in Q1 2026, selling an estimated $240K and leaving 43,087 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3531.
Barclays first reported a position in INGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.79M in Q4 2015. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.
- Barclays held 43,087 shares of Inogen worth $266K as of Q1 2026.
- Barclays sold 38,893 Inogen shares in Q1 2026, an estimated $240K.
- Inogen made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3531 holding.
- Barclays first reported a position in Inogen in Q1 2014 and has held it in 49 quarters since.
- Barclays's Inogen position peaked at $3.79M in Q4 2015.
- 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.